News Digest / Ticker: PHGE

Ticker: PHGE

10:04am, Wednesday, Aug 13, 2025

BiomX advances two phage programs; BX004 Phase 2b underway, cash-runway and funding risk

BiomX Inc. (NYSE: PHGE) - quick read What's happening inside: BiomX is advancing two core clinical programs after its APT acquisition (March 2024): BX004 (CF inhaled phage) has entered a randomized Phase 2b with first patient dosed July 14, 2025; BX211 (DFO) reported positive Phase 2 results in M...